|  Help  |  About  |  Contact Us

Publication : The Dual-Antigen Ad5 COVID-19 vaccine delivered as an intranasal plus subcutaneous prime elicits Th1 dominant T-cell and humoral responses in CD-1 mice.

First Author  Rice A Year  2021
Journal  bioRxiv Mgi Jnum  J:303210
Mgi Id  MGI:6512381 Doi  10.1101/2021.03.22.436476
Citation  Rice A, et al. (2021) The Dual-Antigen Ad5 COVID-19 vaccine delivered as an intranasal plus subcutaneous prime elicits Th1 dominant T-cell and humoral responses in CD-1 mice. bioRxiv
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

4 Authors

1 Bio Entities

Trail: Publication

0 Expression